Advertisement

Journal of Clinical Immunology

, Volume 26, Issue 6, pp 533–545 | Cite as

Detection of Cellular Immunity to Rabies Antigens in Human Vaccinees

  • Susan M. MooreEmail author
  • Melinda J. Wilkerson
  • Rolan D. Davis
  • Carol R. Wyatt
  • Deborah J. Briggs
Article

 

A nonradioactive multi-parameter flow cytometry assay was developed to identify antigen-specific lymphocytes in human subjects previously vaccinated against rabies virus and was subsequently compared to the standard tritiated thymidine method. A cell tracking dye, carboxyfluorescein succinimidyl ester, was used in combination with surface label for CD4 and CD8 cells in order to determine the response of lymphocytes to killed rabies virus in an antigen recall assay. The rabies virus-specific lymphocyte response was compared to the humoral immune response in each of ten vaccinated and five non-vaccinated subjects. Lymphocyte responses to rabies virus were observed in all ten vaccinated subjects; some noted as early as 3 days after stimulation while others were not until 7 days after stimulation. There was good agreement between the proliferation index of the CFSE assay and the simulation index of the [3H]thymidine assay (kappa statistic=0.73). An inverse relationship was detected between the level of rabies virus neutralizing antibody (RVNA) and the lymphocyte response to inactivated rabies virus in the vaccinated subjects. The association between cytokines production and level of humoral and cellular response was investigated in four representative subjects. Two vaccinated subjects with high proliferation indices and low RVNA titers produced Th1 type cytokines to rabies virus stimulation, whereas two vaccinated individuals with low proliferation indices and high RVNA titers responses did not produce these cytokines.

KEY WORDS

Carboxyfluoroscein succinimidyl ester in vitro proliferation flow cytometry rabies vaccine response cytokines 

Notes

ACKNOWLEDGMENTS

We would like to thank the rabies vaccinated and non-vaccinated individuals who participated in this study. We are indebted to Tammy Koopman and Mehrdad Ameri for their technical assistance and review of the manuscript and to Teri Ricke for her help with the RFFIT testing.

REFERENCES

  1. 1.
    Haupt W: Rabies–Risk of exposure and current trends in prevention of human cases. Vaccine 17:1742–1749, 1999PubMedCrossRefGoogle Scholar
  2. 2.
    Dietzschold B, Morimoto K, Hooper DC: Mechanisms of virus-induced neuronal damage and the clearance of viruses from the CNS. Curr Top Microbiol Immunol 253:145–155, 2001PubMedGoogle Scholar
  3. 3.
    Hooper DC, Sauder C, Scott GS, Dietzschold B, Richt JA: Immunopathology and immunoprotection in CNS virus infections: Mechanisms of virus clearance from the CNS. Curr Top Microbiol Immunol 265:163–182, 2002PubMedGoogle Scholar
  4. 4.
    Kuwert EK, Barsenbach J, Werner J, Marcus I, Scheiermann N, Grosse-Wilde H et al.: Early/high and late/low responders among HDCS vaccinees. In Cell Culture Rabies Vaccines and Their Protective Effect in Man, EK Kuwert, RJ Wiktor, H Koprowski (eds). Geneva, International Green Cross, 1981, pp 160–168Google Scholar
  5. 5.
    Strady C, Jaussaud R, Beguinot I, Lienard M, Strady A: Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: Validation of a new booster dose strategy. Vaccine 18:2661–2667, 2000PubMedCrossRefGoogle Scholar
  6. 6.
    Aubert MF: Practical significance of rabies antibodies in cats and dogs. Rev Sci Tech 11:735–760, 1992PubMedGoogle Scholar
  7. 7.
    Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B: Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 72:3711–3719, 1998PubMedGoogle Scholar
  8. 8.
    Garenne M, Lafon M: Sexist diseases. Perspect Biol Med 41:176–189, 1998PubMedGoogle Scholar
  9. 9.
    Lafon M: Immunology. In Rabies, AC Jackson, WH Wunner (eds). San Diego, CA, Academic Press, 2002, pp 351–371Google Scholar
  10. 10.
    Hooper DC: The role of immune responses in the pathogenesis of rabies. J Neurovirol 11:88–92, 2005PubMedCrossRefGoogle Scholar
  11. 11.
    Thraenhart O, Kreuzfelder E, Hillebrandt M, Marcus I, Ramakrishnan K, Fu ZF, et al.: Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol 71:287–292, 1994PubMedCrossRefGoogle Scholar
  12. 12.
    Herzog M, Fritzell C, Lafage M, Montano Hirose JA, Scott-Algara D, Lafon M: T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination. Clin Exp Immunol 85:224–230, 1991PubMedCrossRefGoogle Scholar
  13. 13.
    Fulcher D, Wong S: Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol Cell Biol 77:559–564, 1999PubMedCrossRefGoogle Scholar
  14. 14.
    Givan AL, Fisher JL, Waugh M, Ernstoff MS, Wallace PK: A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 230:99–112, 1999PubMedCrossRefGoogle Scholar
  15. 15.
    Smith JS, Yager PA, Baer GM: A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 48:535–541, 1973PubMedGoogle Scholar
  16. 16.
    Habel K: Habel test for potency. In Laboratory Techniques in Rabies, FX Meslin, MM Kaplan, H Koprowski (eds). Geneva, World Health Organization, 1996, pp 369-373Google Scholar
  17. 17.
    Centers for Disease Control and Prevention: Recommendations of the Advisory Committee on Immunization Practices (ACIP). 48: 1–21. United States, Morbidity and Mortality Weekly Report, 1999Google Scholar
  18. 18.
    World Health Organization: World Health Organization Expert Committee on Rabies: Eighth Report. 824. Geneva, WHO Press, WHO Technical Report Series, 1992Google Scholar
  19. 19.
    Altman DG: Practical Statistics for Medical Research. London, Chapman and Hall, 1991Google Scholar
  20. 20.
    Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N et al.: Memory T cells and vaccines. Vaccine 21:419–430, 2003PubMedCrossRefGoogle Scholar
  21. 21.
    Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D et al.: Evidence for a viral superantigen in humans. Nature 358:507–510, 1992PubMedCrossRefGoogle Scholar
  22. 22.
    Wells AD, Gudmundsdottir H, Turka LA: Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 100:3173–3183, 1997PubMedCrossRefGoogle Scholar
  23. 23.
    Maino VC: Rapid assessment of antigen induced cytokine expression in memory T cells by flow cytometry. Vet Immunol Immunopathol 63:199–207, 1998PubMedCrossRefGoogle Scholar
  24. 24.
    Lagrelius M, Jones P, Franck K, Gaines H: Cytokine detection by multiplex technology useful for assessing antigen specific cytokine profiles and kinetics in whole blood cultured up to seven days. Cytokine 33:156–165, 2006PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Susan M. Moore
    • 1
    • 2
    Email author
  • Melinda J. Wilkerson
    • 1
  • Rolan D. Davis
    • 1
  • Carol R. Wyatt
    • 1
  • Deborah J. Briggs
    • 1
  1. 1.Department of Diagnostic MedicineCollege of Veterinary Medicine, Kansas State UniversityManhattanUSA
  2. 2.Department of Diagnostic MedicineCollege of Veterinary Medicine, Kansas State UniversityManhattanUSA

Personalised recommendations